These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3158119)
41. Antigen-specific suppression of anti-influenza antibody production in man. Possible role of a membrane-antigen complex. McCaughan GW; Brown MH; Basten A Eur J Immunol; 1985 Mar; 15(3):282-90. PubMed ID: 3156747 [TBL] [Abstract][Full Text] [Related]
42. CD40 ligand preferentially modulates immune response and enhances protection against influenza virus. Hashem AM; Gravel C; Chen Z; Yi Y; Tocchi M; Jaentschke B; Fan X; Li C; Rosu-Myles M; Pereboev A; He R; Wang J; Li X J Immunol; 2014 Jul; 193(2):722-34. PubMed ID: 24928989 [TBL] [Abstract][Full Text] [Related]
43. Effects of cell mediated immunity in influenza virus infection in mice. Schulman JL; Petigrow C; Woodruff J Dev Biol Stand; 1977 Jun 1-3; 39():385-90. PubMed ID: 304820 [TBL] [Abstract][Full Text] [Related]
44. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection. Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG Eur J Immunol; 2001 May; 31(5):1523-30. PubMed ID: 11465109 [TBL] [Abstract][Full Text] [Related]
45. [Effect of adenovirus and influenza virus on the thymus-dependent and thymus-independent immune response]. Frolov AF; Borisova VA Vopr Virusol; 1984; 29(1):79-82. PubMed ID: 6324492 [TBL] [Abstract][Full Text] [Related]
46. [Long-term effect of oral immunization against influenza with a live vaccine in mice]. Noack K; Bergmann KC; Pohl WD; Tischner H; Luther P Z Erkr Atmungsorgane; 1985; 164(1):79-82. PubMed ID: 3984402 [TBL] [Abstract][Full Text] [Related]
47. Partial depletion of natural CD4⁺CD25⁺ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection. Betts RJ; Ho AW; Kemeny DM PLoS One; 2011; 6(11):e27849. PubMed ID: 22125630 [TBL] [Abstract][Full Text] [Related]
48. Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. Sarawar SR; Sangster M; Coffman RL; Doherty PC J Immunol; 1994 Aug; 153(3):1246-53. PubMed ID: 8027552 [TBL] [Abstract][Full Text] [Related]
49. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. Kris RM; Asofsky R; Evans CB; Small PA J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265 [TBL] [Abstract][Full Text] [Related]
50. [Functional activity of antibody-producing cells in mice with experimental influenza]. Dukhin AI Vestn Akad Med Nauk SSSR; 1991; (4):8-11. PubMed ID: 1866992 [TBL] [Abstract][Full Text] [Related]
51. Reduction of influenza virus pathogenesis by exposure to 0.5 ppm ozone. Jakab GJ; Hmieleski RR J Toxicol Environ Health; 1988; 23(4):455-72. PubMed ID: 3361616 [TBL] [Abstract][Full Text] [Related]
52. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection. Garulli B; Meola M; Stillitano MG; Kawaoka Y; Castrucci MR Virology; 2007 May; 361(2):274-82. PubMed ID: 17222437 [TBL] [Abstract][Full Text] [Related]
53. The properties of the unique age-associated B cell subset reveal a shift in strategy of immune response with age. Swain SL; Kugler-Umana O; Kuang Y; Zhang W Cell Immunol; 2017 Nov; 321():52-60. PubMed ID: 28712455 [TBL] [Abstract][Full Text] [Related]
54. The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro. Bodewes R; Geelhoed-Mieras MM; Heldens JG; Glover J; Lambrecht BN; Fouchier RA; Osterhaus AD; Rimmelzwaan GF Vaccine; 2009 Nov; 27(49):6833-9. PubMed ID: 19772942 [TBL] [Abstract][Full Text] [Related]
55. Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions. Coleclough C; Sealy R; Surman S; Marshall DR; Hurwitz JL Scand J Immunol; 2005 Jul; 62 Suppl 1():73-83. PubMed ID: 15953188 [TBL] [Abstract][Full Text] [Related]
56. Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. Nguyen HH; Zemlin M; Ivanov II; Andrasi J; Zemlin C; Vu HL; Schelonka R; Schroeder HW; Mestecky J J Virol; 2007 Sep; 81(17):9331-8. PubMed ID: 17567700 [TBL] [Abstract][Full Text] [Related]
57. Protection of mice from lethal influenza by defective interfering virus: T cell responses. McLain L; Morgan DJ; Dimmock NJ J Gen Virol; 1992 Feb; 73 ( Pt 2)():375-81. PubMed ID: 1371542 [TBL] [Abstract][Full Text] [Related]
58. An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses. Ada GL; Leung KN; Ertl H Immunol Rev; 1981; 58():5-24. PubMed ID: 6273293 [No Abstract] [Full Text] [Related]
59. [The effect of kemantane on T-helpers and T-suppressors]. Man'ko VM; Pinegin BV; Rudneva TB; Zavgorodniĭ SG; Blagonravova OL; Gadzhiev RI; Artsimovich NG Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):66-7. PubMed ID: 1836926 [TBL] [Abstract][Full Text] [Related]
60. [The dynamics of the T-lymphocyte subpopulations and the peroxidase activity of the neutrophils in children immunized with a live mumps vaccine]. Zakharova TR; Bolotovskiĭ VM; Titova NS; Gelikman BG Zh Mikrobiol Epidemiol Immunobiol; 1990 Feb; (2):51-5. PubMed ID: 2160767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]